This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Feb;10(2):285-8.

doi: 10.1002/lt.20077.

Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio?

PMID: 14762868
DOI: 10.1002/lt.20077

Free article

Review

Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio?

Robert J Porte. Liver Transpl. 2004 Feb.

Free article

. 2004 Feb;10(2):285-8.

doi: 10.1002/lt.20077.

Author

PMID: 14762868
DOI: 10.1002/lt.20077

No abstract available

PubMed Disclaimer

Comment on

The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
Dalmau A, Sabaté A, Koo M, Bartolomé C, Rafecas A, Figueras J, Jaurrieta E. Dalmau A, et al. Liver Transpl. 2004 Feb;10(2):279-84. doi: 10.1002/lt.20075. Liver Transpl. 2004. PMID: 14762867 Clinical Trial.
Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated?
Ramsay MA, Randall HB, Burton EC. Ramsay MA, et al. Liver Transpl. 2004 Feb;10(2):310-4. doi: 10.1002/lt.20064. Liver Transpl. 2004. PMID: 14762872

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information